<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24948444</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>López Nuñez, Carmen</dc:author>
<dc:author>Louvriex Freire, René</dc:author>
<dc:author>Ferri Iglesias, María José</dc:author>
<dc:author>Figa Francesch, Montserrat</dc:author>
<dc:author>Virolés Torrent, Silvia</dc:author>
<dc:author>Hombrados Verde, Manoli</dc:author>
<dc:author>Acero Fernández, Doroteo</dc:author>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2015 Feb </dc:date>
<dc:title xml:lang="es">La interrupción precoz del tratamiento triple con telaprevir de la hepatitis crónica C por efecto adverso grave no presupone necesariamente el fracaso del tratamiento.</dc:title>
<dc:title xml:lang="en">[Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].</dc:title>
<dc:publisher>Gastroenterologia y hepatologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
